Skip to main content
SpringerLink
Log in

Kardiale Erkrankungen

  • Chapter
Neugeborenen-intensivmedizin

  • 1463 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336:525–533

    Google Scholar 

  2. (1999) Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed 80:F38–42

    Google Scholar 

  3. Achanti B, Yeh TF, Pildes RS (1986) Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med 9:250–253

    PubMed  CAS  Google Scholar 

  4. Ahlfors CE (2004) Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 144:386–388

    Article  PubMed  CAS  Google Scholar 

  5. Alwi M, Choo KK, Latiff HA, Kandavello G, Samion H, Mulyadi MD (2004) Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 44:438–445

    Article  PubMed  Google Scholar 

  6. Arlettaz R, Bauschatz AS, Monkhoff M, Essers B, Bauersfeld U (2006) The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr 165:94–98

    Article  PubMed  Google Scholar 

  7. AWMF-Leitlinien (2005) Leitlinien zur Diagnostik und Therapie von Erkrankungen des Herzens und des Kreislaufs bei Kindern und Jugendlichen. http://leitlinien.net

    Google Scholar 

  8. Bahrami KR, Van Meurs KP (2005) ECMO for neonatal respiratory failure. Semin Perinatol 29:15–23

    Article  PubMed  Google Scholar 

  9. Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, Kulik TJ, Spray TL, Akbary A, Miller RP, Wernovsky G (2004) A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn. 31:43–59

    Article  PubMed  CAS  Google Scholar 

  10. Balaguru D, Auslender M (2000) Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol 12:81–90

    Article  PubMed  Google Scholar 

  11. Bassler D, Choong K, McNamara P, Kirpalani H (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 89:1–5

    Article  PubMed  Google Scholar 

  12. Bell E, Acarregui M (2001) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev: CD000503

    Google Scholar 

  13. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472

    Article  PubMed  Google Scholar 

  14. Brown JW, Park HJ, Turrentine MW (2001) Arterial switch operation: factors impacting survival in the current era. Ann Thorac Surg 71:1978–1984

    Article  PubMed  CAS  Google Scholar 

  15. Brown KL, Miles F, Sullivan ID, Hoskote A, Verhulst L, Ridout DA, Goldman AP (2005) Outcome in neonates with congenital heart disease referred for respiratory extracorporeal membrane oxygenation. Acta Paediatr 94:1280–1284

    Article  PubMed  Google Scholar 

  16. Buck ML (2005) Clinical experience with spironolactone in pediatrics. Ann Pharmacother 39:823–828

    Article  PubMed  CAS  Google Scholar 

  17. Capomolla S, Febo O, Opasich C, Guazzotti G, Caporotondi A, La Rovere MT, Gnemmi M, Mortara A, Vona M, Pinna GD, Maestri R, Cobelli F (2001) Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Eur J Heart Fail 3:601–610

    Article  PubMed  CAS  Google Scholar 

  18. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354:579–587

    Article  PubMed  CAS  Google Scholar 

  19. Channer K, McLean K et al. (1994) Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71:146–150

    PubMed  CAS  Google Scholar 

  20. Cooke L, Steer P, Woodgate P (2003) Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev:CD003745

    Google Scholar 

  21. Cornfield DN, Maynard RC, de Regnier RA, Guiang SF, 3rd, Barbato JE, Milla CE (1999) Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 104:1089–1094

    Article  PubMed  CAS  Google Scholar 

  22. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10:790–798

    Article  PubMed  CAS  Google Scholar 

  23. Crosson JE, Etheridge SP, Milstein S, Hesslein PS, Dunnigan A (1994) Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 74:155–160

    Article  PubMed  CAS  Google Scholar 

  24. Dalton HJ, Rycus PT, Conrad SA (2005) Update on extracorporeal life support 2004. Semin Perinatol 29:24–33

    Article  PubMed  Google Scholar 

  25. Day RW, Etheridge SP, Veasy LG, Jenson CB, Hillman ND, Di Russo GB, Thorne JK, Doty DB, McGough EC, Hawkins JA (2006) Single ventricle palliation: greater risk of complications with the Fontan procedure than with the bidirectional Glenn procedure alone. Int J Cardiol 106:201–210

    Article  PubMed  Google Scholar 

  26. de Lagausie P, de Buys-Roessingh A, Ferkdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, Berrebi D (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 205:112–118

    Article  PubMed  CAS  Google Scholar 

  27. Deloof E, Devlieger H, Van Hoestenberghe R, Van den Berghe K, Daenen W, Gewillig M (1997) Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr 156:521–523

    Article  PubMed  CAS  Google Scholar 

  28. Dorostkar PC, Arko MK, Baird TM, Rodriguez S, Martin RJ (2005) Asystole and severe bradycardia in preterm infants. Biol Neonate 88:299–305

    Article  PubMed  Google Scholar 

  29. Drummond WH (1984) Use of cardiotonic therapy in the management of infants with PPHN. Clin Perinatol 11:715–728

    PubMed  CAS  Google Scholar 

  30. Duggal B, Pratap U, Slavik Z, Kaplanova J, Macrae D (2005) Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect? Pediatr Cardiol. 26:642–645

    Article  PubMed  CAS  Google Scholar 

  31. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL (2001) Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 122:440–448

    Article  PubMed  CAS  Google Scholar 

  32. Elbourne D, Field D, Mugford M (2002) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev.Art. No.: CD001340

    Google Scholar 

  33. English RF, Janosky JE, Ettedgui JA, Webber SA (2004) Outcomes for children with acute myocarditis. Cardiol Young 14:488–493

    Article  PubMed  Google Scholar 

  34. Etheridge SP, Craig JE, Compton SJ (2001) Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 141:105–110

    Article  PubMed  CAS  Google Scholar 

  35. Evans N, Iyer P (1993) Change in blood pressure after treatment of patent ductus arteriosus with indomethacin. Arch Dis Child 68:584–587

    Article  PubMed  CAS  Google Scholar 

  36. Evans N, Kluckow M, Simmons M, Osborn D (2002) Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87:F181–184

    Article  PubMed  CAS  Google Scholar 

  37. Evans N, Osborn D, Kluckow M (2005) Preterm circulatory support is more complex than just blood pressure. Pediatrics 115:1114–1115; author reply 1115–1116

    Article  PubMed  Google Scholar 

  38. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, Downing JW (1985) Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 121:31–36

    PubMed  CAS  Google Scholar 

  39. Fineman JR, Soifer SJ, Heymann MA (1995) Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57:115–134

    Article  PubMed  CAS  Google Scholar 

  40. Finer NN, Barrington KJ (2001) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev:CD000399

    Google Scholar 

  41. Fowlie P, Davis P (2002) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev: CD000174

    Google Scholar 

  42. Garty Y, Veldtman G, Lee K, Benson L (2005) Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol 17:318–322

    PubMed  Google Scholar 

  43. Glass P, Wagner AE, Papero PH, Rajasingham SR, Civitello LA, Kjaer MS, Coffman CE, Getson PR, Short BL (1995) Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 127:447–457

    Article  PubMed  CAS  Google Scholar 

  44. Glen S, Burns J, Bloomfield P (2004) Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects. Heart 90:1321–1325

    Article  PubMed  CAS  Google Scholar 

  45. Goldberg CS, Gomez CA (2003) Hypoplastic left heart syndrome: new developments and current controversies. Semin Neonatol 8:461–468

    Article  PubMed  Google Scholar 

  46. Goldmuntz E (2005) DiGeorge syndrome: new insights. Clin Perinatol 32:963–978, ix–x

    PubMed  Google Scholar 

  47. Habib DM, Padbury JF, Anas NG, Perkin RM, Minegar C (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 20:601–608

    PubMed  CAS  Google Scholar 

  48. Hammerman C, Aramburo MJ (1990) Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 117:771–776

    PubMed  CAS  Google Scholar 

  49. Hardart GE, Hardart MK, Arnold JH (2004) Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J Pediatr 145:184–189

    Article  PubMed  Google Scholar 

  50. Hausdorf G (2000) Intensivtherapie angeborener Herzfehler. Steinkopff, Darmstadt

    Google Scholar 

  51. Hawkins JA, Minich LL, Tani LY, Day RW, Judd VE, Shaddy RE, McGough EC (1998) Late results and reintervention after aortic valvotomy for critical aortic stenosis in neonates and infants. Ann Thorac Surg 65:1758–1762; discussion 1763

    Article  PubMed  CAS  Google Scholar 

  52. Hebra A, Brown MF, Hirschl RB, McGeehin K, O’Neill JA, Jr., Norwood WI, Ross AJ, 3rd (1993) Mesenteric ischemia in hypoplastic left heart syndrome. J Pediatr Surg 28:606–611

    Article  PubMed  CAS  Google Scholar 

  53. Hobbins S, Fowler R (1981) Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch Dis Child 56:934–938

    PubMed  CAS  Google Scholar 

  54. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD (1997) Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25:352–359

    Article  PubMed  CAS  Google Scholar 

  55. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 107:996–1002

    Article  PubMed  CAS  Google Scholar 

  56. Howard LS, Morrell NW (2005) New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev 6:285–291

    Article  PubMed  Google Scholar 

  57. Iyer P, Evans N (1994) Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70:F112–117

    PubMed  CAS  Google Scholar 

  58. Juliana AE, Abbad FC (2005) Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164:626–629

    Article  PubMed  Google Scholar 

  59. Kelley J (1986) Digoxinreceptors in the neonate. In: EF D, MA E, WM G, WJ R (eds) Pediatric cardiology. Springer, Berlin Heidelberg New York Tokyo, p 1233 ff

    Google Scholar 

  60. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131:55–62

    Article  PubMed  CAS  Google Scholar 

  61. Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774–779

    Article  PubMed  CAS  Google Scholar 

  62. Koehne P, Rüdiger M (2005) Persistierender Ductus arteriosus des Frühgeborenen. In: Bassler D, Forster J, Antes G (eds) Evidenz-basierte Pädiatrie, Ergänzungswerk 1. Thieme, p 1–28

    Google Scholar 

  63. Koppel RI, Druschel CM, Carter T, Goldberg BE, Mehta PN, Talwar R, Bierman FZ (2003) Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics 111:451–455

    Article  PubMed  Google Scholar 

  64. Kostelka M, Walther T, Geerdts I, Rastan A, Jacobs S, Dahnert I, Kiefer H, Bellinghausen W, Mohr FW (2004) Primary repair for aortic arch obstruction associated with ventricular septal defect. Ann Thorac Surg 78:1989–1993; discussion 1993

    Article  PubMed  Google Scholar 

  65. Latifi S, Lidsky K, Blumer JL (2000) Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 12:57–79

    Article  PubMed  Google Scholar 

  66. Levi D, Marelli D, Plunkett M, Eisenring C, Sadeghi A, Galindo A, Fazio D, Guplta A, Burch C, George B, Laks H (2002) Use of assist devices and ECMO to bridge pediatric patients with cardiomyophaty to transplantation

    Google Scholar 

  67. Lewis A, Freed M, Heymann M, Roehl S, Kinsey R (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–898

    PubMed  CAS  Google Scholar 

  68. Lin HC, Su BH, Lin TW, Tsai CH, Yeh TF (2005) System-based strategy for the management of meconium aspiration syndrome: 198 consecutive cases observations. Acta Paediatr Taiwan 46:67–71

    PubMed  Google Scholar 

  69. Long W (1990) Fetal and neonatal cardiology. Saunders, Philadelphia

    Google Scholar 

  70. Luciani GB, Nichani S, Chang AC, Wells WJ, Newth CJ, Starnes VA (1997) Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. Ann Thorac Surg 64:1133–1139

    Article  PubMed  CAS  Google Scholar 

  71. Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ, 3rd (2000) Survival after reconstructive surgery for hypoplastic left heart syndrome: A 15-year experience from a single institution. Circulation 102:136–141

    Google Scholar 

  72. Malviya M, Ohlsson A, Shah S (2003) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev:CD003951

    Google Scholar 

  73. Marmon LM, Bye MR, Haas JM, Balsara RK, Dunn JM (1984) Vascular rings and slings: long-term follow-up of pulmonary function. J Pediatr Surg 19:683–692

    Article  PubMed  CAS  Google Scholar 

  74. McCarthy RE, 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695

    Article  PubMed  Google Scholar 

  75. McCrindle BW (2005) Is balloon aortic valvuloplasty a feasible treatment for neonates and young infants with aortic valve stenosis? Nat Clin Pract Cardiovasc Med 2:340–341

    Article  PubMed  Google Scholar 

  76. McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW, Spray TL, Wernovsky G (2000) Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 106:1080–1087

    Article  PubMed  CAS  Google Scholar 

  77. Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA (2005) Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 40:1100–1105

    Article  PubMed  Google Scholar 

  78. Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR (1988) Furosemide pharmacokinetics in very low birth weight infants. J Pediatr 112:653–657

    Article  PubMed  CAS  Google Scholar 

  79. Munro MJ, Walker AM, Barfield CP (2004) Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 114:1591–1596

    Article  PubMed  Google Scholar 

  80. Neches W, Park S, Ettedgui J (1997) Tetralogy of Fallot and Tetralogy of Fallot with Pulmonary Atresia. In: Garson A, Bricker JT, Fisher D, Neish S (eds) The science and practice of pediatric cardiology. Williams and Wilkins, p 1400

    Google Scholar 

  81. Obladen M, Koehne P (2005) Interventions for Persisting Ductus Arteriosus in the Preterm Infant. Springer Heidelberg

    Google Scholar 

  82. Ohye RG, Gomez CA, Ohye BJ, Goldberg CS, Bove EL (2001) The Ross/Konno procedure in neonates and infants: intermediate-term survival and autograft function. Ann Thorac Surg 72:823–830

    Article  PubMed  CAS  Google Scholar 

  83. Osborn DA, Evans N (2004) Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev:CD002055

    Google Scholar 

  84. Paradisis M, Osborn DA (2004) Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev:CD003958

    Google Scholar 

  85. Park Y, Lucas VW, Sklansky MS, Kashani IA, Rothman A (1997) Balloon angioplasty of native aortic coarctation in infants 3 months of age and younger. Am Heart J 134:917–923

    Article  PubMed  CAS  Google Scholar 

  86. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44:513–519

    Article  PubMed  Google Scholar 

  87. Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G (2000) Supraventrikuläre Tachykardien bei Säuglingen, Kindern und Jugendlichen: Diagnostik-Medikamentöse und interventionelle Therapie. Z Kardiol 89:546–558

    Article  PubMed  CAS  Google Scholar 

  88. Paul T, Pfammatter JP (1997) Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 18:118–126

    Article  PubMed  CAS  Google Scholar 

  89. Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J, Cabanas F (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115:1501–1512

    Article  PubMed  Google Scholar 

  90. Pfammatter JP, Stocker FP (1998) Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood. Am J Cardiol 82:72–75

    Article  PubMed  CAS  Google Scholar 

  91. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717

    Article  PubMed  CAS  Google Scholar 

  92. Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114:1297–1304

    Article  PubMed  Google Scholar 

  93. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544–548

    PubMed  CAS  Google Scholar 

  94. Rosati E, Chitano G, Dipaola L, De Felice C, Latini G (2005) Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med 33:455–457

    Article  PubMed  Google Scholar 

  95. Roy DL, McIntyre L, Human DG, Nanton MA, Sherman GJ, Allen LM, Finley JP (1994) Trends in the prevalence of congenital heart disease: comprehensive observations over a 24-year period in a defined region of Canada. Can J Cardiol 10:821–826

    PubMed  CAS  Google Scholar 

  96. Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR (2003) Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. J Perinatol 23: 98–103

    Article  PubMed  CAS  Google Scholar 

  97. Saul JP, Walsh EP, Triedman JK (1995) Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol 6:1129–1148

    PubMed  CAS  Google Scholar 

  98. Shah S, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev: CD004213

    Google Scholar 

  99. Shann F (2003) Drug doses. Collective Ltd, Parkville Australia

    Google Scholar 

  100. Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Boomsma F, van den Anker JN, Tibboel D (2005) Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 90:F36–40

    Article  PubMed  CAS  Google Scholar 

  101. Skinner J, Alverson D, Hunter S (2000) Echocardiography for the neonatologist. Churchill Livingstone Elsevier

    Google Scholar 

  102. Smith RR, Wray J, Khaghani A, Yacoub M (2005) Ten year survival after paediatric heart transplantation: a single centre experience. Eur J Cardiothorac Surg 27:790–794

    Article  PubMed  Google Scholar 

  103. Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC, 3rd (1997) Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130:417–422

    Article  PubMed  CAS  Google Scholar 

  104. Stiller B, Dähnert I, Weng Y, Hennig E, Hetzer R, Lange P (1999) Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 82:237–240

    PubMed  CAS  Google Scholar 

  105. Stiller B, Hetzer R, Weng Y, Hummel M, Hennig E, Nagdyman N, Ewert P, Lehmkuhl H, Lange P (2003) Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant 22:1201–1208

    Article  PubMed  Google Scholar 

  106. Stiller B, Lemmer J, Merkle F, Alexi-Meskishvili V, Weng Y, Hübler M, Koster A, Drews T, Lange P, Hetzer R (2004) Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device. Intensive Care Medicine 30:1814–1820

    Article  PubMed  Google Scholar 

  107. Stiller B, Weng Y, Hubler M, Lemmer J, Nagdyman N, Redlin M, Lange P, Hetzer R (2005) Pneumatic pulsatile ventricular assist devices in children under 1 year of age. Eur J Cardiothorac Surg.

    Google Scholar 

  108. Subhedar N, Shaw N (2006) Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev.

    Google Scholar 

  109. Subhedar NV, Shaw NJ (2003) Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev:CD001242

    Google Scholar 

  110. Tanner K, Sabrine N, Wren C (2005) Cardiovascular malformations among preterm infants. Pediatrics 116:e833–838

    Article  PubMed  Google Scholar 

  111. Thompson RB, van den Bos EJ, Esposito DJ, Owen CH, Glower DD (2003) The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts. Eur J Heart Fail 5:741–749

    Article  PubMed  Google Scholar 

  112. Tibballs J, Chow CW (2002) Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of the newborn. J Paediatr Child Health 38:397–400

    Article  PubMed  CAS  Google Scholar 

  113. Travadi JN, Patole SK (2003) Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 36:529–535

    Article  PubMed  CAS  Google Scholar 

  114. von Schnakenburg C, Fink C, Peuster M, Wessel A, Vazquez-Jimenez JF (2002) Permanent pacemaker implantation in a 1,445 g preterm neonate on the first day of life. Thorac Cardiovasc Surg 50:363–365

    Article  Google Scholar 

  115. Ward K, Mullins C (1997) Anomalous pulmonary venous connections, vein stenosis, and atresia of the common vein. In: Garson A, Bricker JT, Fisher D, Neish S. The science and practice of pediatric cardiology. p 1431–1445

    Google Scholar 

  116. Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288:L480–487

    Article  PubMed  CAS  Google Scholar 

  117. Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD (2001) Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 89:67–79

    Article  PubMed  CAS  Google Scholar 

  118. Weon YC, Yoshida Y, Sachet M, Mahadevan J, Alvarez H, Rodesch G, Lasjaunias P (2005) Supratentorial cerebral arteriovenous fistulas (AVFs) in children: review of 41 cases with 63 non choroidal single-hole AVFs. Acta Neurochir (Wien) 147:17–31; discussion 31

    Article  CAS  Google Scholar 

  119. Wetter J, Belli E, Sinzobahamvya N, Blaschzok HC, Brecher AM, Urban AE (2001) Transposition of the great arteries associated with ventricular septal defect: surgical results and long-term outcome. Eur J Cardiothorac Surg 20:816–823

    Article  PubMed  CAS  Google Scholar 

  120. Wood AE, Javadpour H, Duff D, Oslizlok P, Walsh K (2004) Is extended arch aortoplasty the operation of choice for infant aortic coarctation? Results of 15 years’ experience in 181 patients. Ann Thorac Surg 77:1353–1357; discussion 1357–1358

    Article  PubMed  Google Scholar 

  121. Hammerman C (1995) Patent ducus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clin Perinatol 22: 457–479

    PubMed  CAS  Google Scholar 

  122. Gevers, M, van Genderingen HR, Lafeber HN, Hack WW (1995) Radial artery blood pressure measurement in neonates: an accurate and convenient technique in clinical practice. J Perinat Med 23: 467–475

    Article  PubMed  CAS  Google Scholar 

  123. Evans N (2006) Which inotrope for which baby? Arch Dis Child Fetal Neonatal Ed 91:F213–F220

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Brigitte Stiller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin

    Michael Obladen (Direktor der Klinik für Neonatologie) (Direktor der Klinik für Neonatologie)

  2. Universitätsklinikum Gießen/Marburg GmbH, Standort Marburg, Baldinger Straße, 35043, Marburg

    Rolf F. Maier (Direktor des Zentrums für Kinder- und Jugendmedizin) (Direktor des Zentrums für Kinder- und Jugendmedizin)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Stiller, B. (2006). Kardiale Erkrankungen. In: Obladen, M., Maier, R.F. (eds) Neugeborenen-intensivmedizin. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33738-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33738-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33737-9

  • Online ISBN: 978-3-540-33738-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation